We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

212 hedge funds and large institutions have $320M invested in Immunogen Inc in 2019 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 32

26% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $10.3M

19% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 54

6% more funds holding

Funds holding: 200 → 212 (+12)

46% less capital invested

Capital invested by funds: $589M → $320M (-$269M)

Holders
212
Holders Change
+12
Holders Change %
+6%
% of All Funds
4.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
64
Reduced
54
Closed
32
Calls
$13.1M
Puts
$10.3M
Net Calls
+$2.72M
Net Calls Change
-$12.4M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$19.7M
2
RG
Redmile Group
California
+$9.44M
3
QF
QVT Financial
New York
+$5.96M
4
DAM
DLD Asset Management
New York
+$5.14M
5
Deutsche Bank
Deutsche Bank
Germany
+$4.88M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.5M
2
Millennium Management
Millennium Management
New York
-$13.5M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$11.5M
4
Citadel Advisors
Citadel Advisors
Florida
-$9.99M
5
Morgan Stanley
Morgan Stanley
New York
-$8.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
51
State of Wisconsin Investment Board
Wisconsin
$560K +$253K +58,500 +39%
FIM
52
Fernwood Investment Management
Massachusetts
$507K – – –
ECM
53
Endurant Capital Management
California
$500K +$799K +184,440 New
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$498K -$22.3K -5,155 -3%
AQR Capital Management
55
AQR Capital Management
Connecticut
$465K +$440K +101,583 +145%
TCM
56
Tekla Capital Management
Massachusetts
$456K – – –
QIM
57
Quantitative Investment Management
Virginia
$451K +$440K +101,469 +156%
PPA
58
Parametric Portfolio Associates
Washington
$446K -$36.4K -8,413 -5%
William Blair & Company
59
William Blair & Company
Illinois
$419K +$40.9K +9,434 +14%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$381K – – –
Fisher Asset Management
61
Fisher Asset Management
Washington
$371K -$4.96K -1,146 -0.8%
UBS AM
62
UBS AM
Illinois
$358K +$91.8K +21,189 +19%
CS
63
Credit Suisse
Switzerland
$346K +$12K +2,771 +2%
UBS Group
64
UBS Group
Switzerland
$342K -$973K -224,559 -64%
Parallax Volatility Advisers
65
Parallax Volatility Advisers
California
$341K +$544K +125,667 New
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$339K +$12.1K +2,785 +2%
Principal Financial Group
67
Principal Financial Group
Iowa
$310K +$897 +207 +0.2%
Natixis Advisors
68
Natixis Advisors
Massachusetts
$309K +$1.82K +421 +0.4%
Barclays
69
Barclays
United Kingdom
$309K +$223K +51,460 +82%
TFCP
70
Twin Focus Capital Partners
Massachusetts
$306K – – –
Group One Trading
71
Group One Trading
Illinois
$281K -$1.84K -425 -0.4%
Stifel Financial
72
Stifel Financial
Missouri
$272K +$111K +25,703 +25%
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$263K +$36.9K +8,527 +10%
Allianz Asset Management
74
Allianz Asset Management
Germany
$251K +$401K +92,492 New
Citigroup
75
Citigroup
New York
$250K -$1.87M -430,608 -82%
1 2
3
4 5

IMGN Hedge Fund Activity: Q1 2019 in Review

212 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2019, worth a combined $320M — down 46% from $589M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IMGN positions and 32 closed out — a net gain of 12 holders — while 64 added to existing stakes and 54 trimmed.

The largest buyer was State Street, adding an estimated $19.7M. The largest seller was Fidelity Investments, cutting an estimated $20.5M.

  • 212 institutional investors held Immunogen Inc (IMGN) as of Q1 2019, up from 200 in Q4 2018.
  • Funds reported $320M of Immunogen Inc stock for Q1 2019, down 46% quarter-over-quarter.
  • 44 funds opened new Immunogen Inc positions in Q1 2019 and 32 closed out, a net change of +12 holders.
  • The largest Immunogen Inc buyer in Q1 2019 was State Street, an estimated $19.7M added.
  • The largest Immunogen Inc seller in Q1 2019 was Fidelity Investments, an estimated $20.5M sold.

Based on aggregated 13F filings for Q1 2019.